Hi,

Yes, I agree with you regarding the combination of Berger and GROMOS force field and requiring validation. I just wanted to point out the interactions between the protein and lipid are treated in the same way, irrespective of the different GROMOS protein force field used (when using the parameters from lipid.itp).

Further on the topic of validation, the only work I know of that has studied in detail the Berger/GROMOS combination (doi:10.1088/0953-8984/18/28/S07) says that when using the standard method as employed by the parameters in lipid.itp:

"the strength of interactions between hydrocarbon lipid tails and proteins is significantly overestimated, causing a decrease in the area per lipid and an increase in lipid ordering"

So the standard approach is probably not the most appropriate way to combine the Berger lipids and the GROMOS protein force field. Rather using combination rules (as for example done in the Berger/OPLS combination) is probably better.

Cheers

Tom

On 19/07/12 00:15, Justin Lemkul wrote:


On 7/18/12 6:57 PM, Thomas Piggot wrote:
Hi,

Justin, I am interested by your comments regarding the CHARMM lipids. In
particular can you elaborate as to why you think that the CHARMM lipids are better than the united-atom ones (such as Berger and several GROMOS variants).


I think there's nothing wrong with Berger lipids, and I myself use them routinely. They do a decent job of reproducing lipid behavior, no question. My own use is motivated by historical reasons primarily since I began work with them many years ago (also around the time that 53A6 was all shiny and new) and I'm trying to keep consistent. It seems to me that the CHARMM36 parameters are very thoroughly validated and are very modern. The Berger lipids were developed a long time ago using very short (by modern comparisons) simulations and old parameter sets that have since been improved upon. There are numerous reasonable lipid models out there, to be sure.

As for the original question, the modifications in going from GROMOS 53A6 to 54A7 will not influence the combination with the Berger lipid parameters, if the most common approach of using the parameters from the 'lipid.itp' file is taken. The interactions between protein and lipid will remain the same, with the van der Waals interactions between the protein and lipid treated using the GROMOS87
parameters as defined in lipid.itp. From my experiences I would strongly
recommend using 54A7 over 53A6, as we have seen instability in short helices in 53A6 that is not reproduced when simulating the same systems with several other
force fields.


I agree with this, I'm just a stickler for validation. A test system using this force field combination should certainly replicate some known behavior. It's generally accepted that any Gromos derivative is compatible with the Berger parameters, but I've never seen anyone demonstrate it systematically aside from their own usage for particular cases.

For the 'best' force field to choose when simulating a membrane-protein system, there is no definitive answer that I (or anyone else) can give you (yet). My own opinion is that currently CHARMM36 is probably too slow (given that I would strongly recommend the use of the CHARMM TIP3P water model with this force field) and that the all-atom protein force fields are probably better than the united-atom ones. This means that I would (for a PC membrane) use Berger for the lipids with OPLS-AA/L or an AMBER force field for the protein. This is just my (current) opinion though, I strongly suggest doing lots of your own reading
before making your mind up.

Indeed.

-Justin


--
Dr Thomas Piggot
University of Southampton, UK.

--
gmx-users mailing list    gmx-users@gromacs.org
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Only plain text messages are allowed!
* Please search the archive at 
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the www interface or send it to gmx-users-requ...@gromacs.org.
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists

Reply via email to